Antibody therapies for Parkinson's and Alzheimer's may cause harmful inflammation (IMAGE)

Scripps Research Institute

Antibody therapies for Parkinson's and Alzheimer's may cause harmful inflammation

Caption

Scientists at Scripps Research find evidence that antibody treatments in clinical trials for neurodegenerative diseases may trigger an inflammatory response that erodes their positive effects. Pictured: Dopaminergic neurons in red and microglia in green.

Credit

Lipton laboratory, Scripps Research

Usage Restrictions

None

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.